These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1825799)

  • 41. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in The Netherlands, 1989-92. National Hepatitis B Steering Committee.
    Grosheide PM; Klokman-Houweling JM; Conyn-van Spaendonck MA
    BMJ; 1995 Nov; 311(7014):1200-2. PubMed ID: 7488896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Active immunization against hepatitis B].
    Wildgrube HJ; Classen M; von Lohr R; Kurth R; Brede HD
    Dtsch Med Wochenschr; 1984 Feb; 109(7):246-50. PubMed ID: 6230216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low dose hepatitis B vaccination in children.
    Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
    N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C; Zanchi R; Seck A; Garin B; Giles-Vernick T; Gody JC; Bata P; Pondy A; Tetang SM; Ba M; Ekobo CS; Rousset D; Sire JM; Maylin S; Chartier L; Njouom R; Vray M
    BMC Infect Dis; 2015 Jul; 15():267. PubMed ID: 26164361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of hepatitis B infection in health care workers after accidental exposure.
    Palmović D
    J Infect; 1987 Nov; 15(3):221-4. PubMed ID: 2961815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine.
    Milne A; Heydon JL; Hindle RC; Pearce NE
    N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the anti-hepatitis B vaccination efficacy in high risk children.
    Nedelcu I; Crăciun D; Târdei G; Ruţă SM; Grancea C; Cernescu C
    Rom J Virol; 1998; 49(1-4):43-51. PubMed ID: 10892425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunglert W; Chumdermpadetsuk S; Sentrakul P; Vandepapelière P; Safary A
    Pediatr Infect Dis J; 1992 Oct; 11(10):816-21. PubMed ID: 1408478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
    Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
    N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).
    Maupas P; Chiron JP; Barin F; Coursaget P; Goudeau A; Perrin J; Denis F; Mar ID
    Lancet; 1981 Feb; 1(8215):289-92. PubMed ID: 6109938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
    Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.